Home drug administration
 

Keywords :   


Tag: drug administration

CASMED Receives China Food and Drug Administration Approval for FORE-SIGHT® Cerebral ...

2013-11-25 06:00:00| Industrial Newsroom - All News for Today

FORE-SIGHT Becomes the Only Foreign-Made Cerebral Oximeter Approved in China<br /> <br /> BRANFORD, Conn. &mdash; CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced that its FORE-SIGHT Cerebral Oximeter has been approved by the China Food and Drug Administration (CFDA) for sale in that country. FORE-SIGHT is the only cerebral oximeter manufactured outside China to have approval from the CDFA.<br /> <br /> "The CFDA ...This story is related to the following:Sensors, Monitors and TransducersPatient Monitoring Equipment | Oxygen Meters

Tags: china food administration drug

 

U.S. Department of Justice and Drug Enforcement Administration - National Drug Threat Assessment Summary 2013

2013-11-22 01:06:23| PortlandOnline

Tags: national department summary administration

 
 

The US Food and Drug Administration is looking to ban artificial trans fat in processed food.

2013-11-08 11:51:02| Food - Topix.net

The US Food and Drug Administration is looking to ban artificial trans fat in processed food such as hot chips.

Tags: food administration drug fat

 

Vertex Submits Supplemental New Drug Application (sNDA) To U.S. Food And Drug Administration For KALYDECO (ivacaftor) Monotherapy For People With Non-G551D Gating Mutations

2013-10-02 05:50:27| drugdiscoveryonline News Articles

Vertex Pharmaceuticals Incorporated recently announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for the approval of KALYDECOTM (ivacaftor) monotherapy for people with cystic fibrosis (CF) ages 6 and older who have at least one non-G551D gating mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene

Tags: with people food application

 

U.S. Food and Drug Administration Approves ABRAXANE in Combination...

2013-09-07 09:04:00| Biotech - Topix.net

Celgene Corporation today announced that the U.S. Food and Drug Administration has approved the Company's supplemental New Drug Application of ABRAXANEA as first-line treatment for patients with metastatic adenocarcinoma of the pancreas, in combination with gemcitabine.

Tags: food administration combination drug

 

Sites : [1] [2] [3] [4] next »